Caredx

CareDx, Inc. is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. They generate revenue primarily through the sale of diagnostic testing services, products, and digital healthcare solutions that improve long-term outcomes for transplant recipients. Founded in 1998, CareDx has a rich history of innovation, including the development of AlloMap and AlloSure, which are non-invasive tests that help monitor organ transplant health. The company's commitment to advancing the field of transplant medicine makes it a leader in the industry.

Recent Posts by Caredx

1-20 of 85